drugset / Trial / NCT02551237

Neoadjuvant Treatment for Advanced Rectal Carcinoma

NCT02551237 ↗

Phase 3 Completed 103 enrolled UNICANCER
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of the study is to compare pre-operative radio-chemotherapy (RT + capecitabine) to a short course RT associated with a delayed surgery, with two primary objectives: the efficacy evaluation (rate of R0 resection) and the preservation of autonomy (score IADL).

Timeline

Start
2016-01-07
Primary completion
2020-08-29
Completion
2022-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Capecitabine Small molecule 800 mg/m2 Oral

Indications